Protara Therapeutics, Inc. (TARA) › Total LiabilitiesProtara Therapeutics, Inc. (TARA) — Total LiabilitiesAnnual figures by period end, from SEC filings.2013-12-31: $9.77M2014-12-31: $2.34M2015-12-31: $4.13M2016-12-31: $5.08M2017-12-31: $9.24M2018-12-31: $3.08M2019-12-31: $3.35M2020-12-31: $3.91M2021-12-31: $10.68M2022-12-31: $11.21M2023-12-31: $10.63M2024-12-31: $14.32M2025-12-31: $13.06M$13.06M2013-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$13.06M-8.8%2026-03-10Balance as of period end2024-12-31$14.32M+34.7%2026-03-10Balance as of period end2023-12-31$10.63M-5.1%2025-03-05Balance as of period end2022-12-31$11.21M+4.9%2024-03-13Balance as of period end2021-12-31$10.68M+172.9%2023-03-08Balance as of period end2020-12-31$3.91M+16.8%2022-03-09Balance as of period end2019-12-31$3.35M+8.9%2021-03-11Balance as of period end2018-12-31$3.08M-66.7%2020-03-20Balance as of period end2017-12-31$9.24M+81.9%2019-03-13Balance as of period end2016-12-31$5.08M+22.9%2018-03-14Balance as of period end2015-12-31$4.13M+76.8%2017-03-16Balance as of period end2014-12-31$2.34M-76.1%2016-03-14Balance as of period end2013-12-31$9.77M—2015-03-20Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)